Healthcare and Life Sciences

Our lawyers have advised domestic and multinational drugs and medical devices companies on wide array of regulatory issues relating to Drugs and Cosmetic Act, 1940, Medical Device Rules, 2017 and New Drugs and Clinical Trial Rules, 2019, including compliance requirements with respect to manufacturing and sales of drugs, registration of medical devices and aspects related to clinical trials. 

​

Our lawyers have been actively involved in understanding and advising players in this sector on matters related to the interactions between HCPs and healthcare companies, including advise on the Indian Medical Council of India Act, 1956 and ethics related regulations thereunder, OPPI Code of Conduct, recommended Uniform Code of Pharmaceutical Marketing Practices as well as and recommended Uniform Code for Medical Devices Marketing Practices.

 

The practice of the Firm in this area extends to all of kinds of commercial transactions concerning this industry, including M&A and commercial arrangements such as purchase and sale, supply contracts  and contract manufacturing. 

​

The Firm has the ability to advise and assist on obtaining all regulatory and operational licenses and registrations in relation to drugs and medical devices.